The partnership will use Synthace's Antha software and Tecan's Te-Chrom automated chromatography system to translate experimental designs into machine-readable instructions for automated equipment. The companies will also work to automate aggregation and structuring of experimental data.

Customers will be able to use the Antha user interface for visual experimental design tools and experimental previews matched to Tecan liquid handling robot configurations. Antha will also automatically link Te-Chrom's analytical data, sample metadata, and experimental context.

The projects will enable customers to execute more ambitious experiments and reduce the risks of delays and human errors, the companies noted.

Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp...

U.S. launches project to promote pharma manufacturing
The U.S. Department of Health and Human Services on May 19 announced a new project to promote U.S.-based pharmaceutical manufacturing to secure the supply...

COVID-19: A double-edged sword for the pharma industry
The COVID-19 pandemic is causing major disruptions to pharmaceutical R&D activities, despite the pressing need for treatments and diagnostics for the...

COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...